NCT02099682View on ClinicalTrials.gov

Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

CompletedOBSERVATIONAL
Enrollment

3,366

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Gastric or Duodenal Ulcers
Interventions
DRUG

Lansoprazole

Lansoprazole Capsules 15/ OD Tablets

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02099682 - Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin | Biotech Hunter | Biotech Hunter